Other therapy.

Molecular profiles and clinical-pathological features of Asian early-stage breast cancer patients

PUBLICATION: SABCS 2020 AUTHORS: Margaret Chen, Ava Kwong, Carolyn Hendricks, Read More

2024-03-25T08:02:55-04:00December 29th, 2020|Evidence, Other, Racial Disparities|

Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens

PUBLICATION: SABCS 2020 AUTHORS: Joseph McKelley, Jennifer Wei, Brian Hoxeng, Read More

2024-03-25T08:01:39-04:00December 29th, 2020|Evidence, Other, Validation|

Differential gene expression and clinical utility of MammaPrint and BluePrint in male breast cancer patients

PUBLICATION: SABCS 2020 AUTHORS: Jennifer A. Crozier, Julie Barone, Kalyan Read More

2024-03-27T06:49:12-04:00December 29th, 2020|Evidence, Other|

The FLEX real world data platform explores new gene expression profiles and investigator-initiated protocols in early stagebreast cancer

PUBLICATION: SABCS 2020 AUTHORS: Laura Lee, Sami Diab, Julie Read More

2024-03-07T10:54:59-05:00December 29th, 2020|Evidence, FLEX TIPS, Other|

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial

PUBLICATION: European Journal of Cancer AUTHORS: Valesca P. Retel, Read More

2024-03-25T11:21:54-04:00September 1st, 2020|Adjuvant, Evidence, Healthcare Economics, MINDACT, Other|
Go to Top